Credo Diagnostics Biomedical Pte. Ltd.
Developer and manufacturer of rapid, portable point-of-care molecular diagnostic platforms and assays for human and veterinary use. The company focuses on integrated sample-to-result workflows that combine nucleic acid extraction and real-time PCR in cartridge formats, multiplex assay development, and data connectivity to healthcare information systems. Offers regulatory-cleared products and conducts post-market monitoring and assay variant analysis.
Industries
Nr. of Employees
small (1-50)
Credo Diagnostics Biomedical Pte. Ltd.
Patents
Using serial dilutions of reference samples to construct a reference table for sigmoidal fitting in real-time PCR copy number analysis
US-10510436-B2
View DetailsMethod for detection CPV 2a, 2b, and 2c and for discrimination wild type from vaccine type
US-10233509-B2
View DetailsMixing and transfer device for materials used in biological and biochemical assays
US-10222307-B2
View Details
Using serial dilutions of reference samples to construct a reference table for sigmoidal fitting in real-time PCR copy number analysis
US-10510436-B2
View DetailsMethod for detection CPV 2a, 2b, and 2c and for discrimination wild type from vaccine type
US-10233509-B2
View DetailsMixing and transfer device for materials used in biological and biochemical assays
US-10222307-B2
View DetailsProducts
Portable point-of-care real-time PCR instrument (human)
Compact rRT-PCR instrument for decentralized human diagnostic testing with touchscreen UI, barcode scanner, real-time fluorescence output and rapid (~20 min) turnaround for many assays.
Cartridge-based multiplex PCR platform (integrated extraction)
All-in-one microfluidic cartridge platform that integrates nucleic acid extraction and multiplex real-time PCR for automated 'sample-in, result-out' testing with multiplex capacity.
Point-of-care data integration software
Local software and interface (plug-and-play) to consolidate instrument outputs, generate reports, and transmit results securely to LIS/EMR/HIS systems.
Veterinary portable PCR platform and assay portfolio
Portable real-time PCR system and a suite of rapid veterinary assays for respiratory, gastrointestinal, blood infection and vector-borne pathogens with ~20-minute turnaround.
VitaSIRO solo™ Instrument
The standalone platform integrates a full workflow of nucleic acid extraction and real-time Polymerase Chain Reaction (real-time PCR) testing in a cartridge-based design, capable of detecting up to 6 targets with a wide range of sample types.
VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay
A multiplex real-time RT-PCR in vitro diagnostic test for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV nucleic acids in nasal and nasopharyngeal swab specimens.
Portable point-of-care real-time PCR instrument (human)
Compact rRT-PCR instrument for decentralized human diagnostic testing with touchscreen UI, barcode scanner, real-time fluorescence output and rapid (~20 min) turnaround for many assays.
Cartridge-based multiplex PCR platform (integrated extraction)
All-in-one microfluidic cartridge platform that integrates nucleic acid extraction and multiplex real-time PCR for automated 'sample-in, result-out' testing with multiplex capacity.
Point-of-care data integration software
Local software and interface (plug-and-play) to consolidate instrument outputs, generate reports, and transmit results securely to LIS/EMR/HIS systems.
Veterinary portable PCR platform and assay portfolio
Portable real-time PCR system and a suite of rapid veterinary assays for respiratory, gastrointestinal, blood infection and vector-borne pathogens with ~20-minute turnaround.
VitaSIRO solo™ Instrument
The standalone platform integrates a full workflow of nucleic acid extraction and real-time Polymerase Chain Reaction (real-time PCR) testing in a cartridge-based design, capable of detecting up to 6 targets with a wide range of sample types.
VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay
A multiplex real-time RT-PCR in vitro diagnostic test for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV nucleic acids in nasal and nasopharyngeal swab specimens.
Services
Partnering to develop and commercialize molecular diagnostic assays and translate concepts into market-ready solutions for POCT and veterinary markets.
Partnering to develop and commercialize molecular diagnostic assays and translate concepts into market-ready solutions for POCT and veterinary markets.
Expertise Areas
- Point-of-care molecular diagnostics
- Multiplex PCR assay development and validation
- Decentralized testing deployment and workflows
- Veterinary molecular diagnostics
Key Technologies
- Real-time PCR (rRT-PCR)
- Multiplex PCR
- Microfluidic cartridge integration
- Nucleic acid extraction (integrated and direct lysis)
News & Updates
Announcement of award recognition for diagnostic innovation.
Report on preparations to start US clinical trials for a near-patient molecular diagnostic system and multiplex respiratory test.
Announcement of expansion of veterinary molecular diagnostic portfolio with additional assays.
Received 'Excellence in Diagnostic Innovation' at a regional MedTech awards event.
Announcement of award recognition for diagnostic innovation.
Report on preparations to start US clinical trials for a near-patient molecular diagnostic system and multiplex respiratory test.
Announcement of expansion of veterinary molecular diagnostic portfolio with additional assays.
Received 'Excellence in Diagnostic Innovation' at a regional MedTech awards event.